Insider Intelligence December 14, 2021
The data: The pandemic accelerated healthcare technology investments in 2021, according to Deloitte’s new Road to Next report.
- The median age of a health tech company at the time of an expansion-stage deal was 7.4 years, per Deloitte’s analysis of PitchBook’s data.
On top of that, pre-money valuations for health tech companies have soared over the past two years:
- The upper quartile of these valuations jumped from $100 million in 2019 to $200 million in 2020 to $331.3 million in 2021, so far.
- And there were 21 public exits encompassing...